D2HG was enriched in IDH1 mutant tumor and serum (Fig. 3g), which was consistent with clinical data showing that IDH1 mutation at R132 resulted in a high concentration of D2HG and high frequency of cachexia in cancer patients. This evidence concerns the gene IDH1 and cancer.